Fixed Phage rebrands to NexaBiome Limited, signifying commitment towards human health sector

  UK-based biotechnology company Fixed Phage has changed its name to NexaBiome Limited, pushing forward in its promise to connect science, technology and healthcare to address the global challenge of antimicrobial resistance (AMR), especially in human health. NexaBiome’s pioneering work in addressing bacterial issues will also continue in the animal and veterinary health sector, cementing…


Fixed Phage accelerates growth strategy with appointment of new CEO and top team

Innovative UK phage biotechnology company, Fixed Phage, has appointed Dr Neil Clelland as its new Chief Executive Officer (CEO). The company has also announced its new Chief Operations Officer (COO) and Executive Chairman. These appointments strengthen the top management team, leading the company as it drives forward its new phase of growth and development. Dr…


New backing accelerates Fixed Phage’s fight against harmful bacteria

Pioneering UK biotechnology business, Fixed Phage, has secured additional investment to scale up its fight against new microbial threats that pose risks to human health and agricultural production. The company, based in Glasgow, has developed an innovative, cost-effective technology that makes bacteriophages – natural antimicrobials – able to eliminate problem bacteria. The patented solution has…